X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8280) 8280
Patent (139) 139
Book Chapter (40) 40
Dissertation (11) 11
Magazine Article (5) 5
Web Resource (3) 3
Book / eBook (1) 1
Newsletter (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5582) 5582
male (4800) 4800
non-alcoholic fatty liver disease (4009) 4009
female (3720) 3720
fatty liver (3316) 3316
middle aged (2864) 2864
liver diseases (2808) 2808
adult (2459) 2459
gastroenterology & hepatology (2412) 2412
animals (2404) 2404
liver (2253) 2253
obesity (2196) 2196
insulin-resistance (2180) 2180
metabolic syndrome (2086) 2086
insulin resistance (2033) 2033
risk factors (1955) 1955
liver - pathology (1739) 1739
steatohepatitis (1654) 1654
fibrosis (1594) 1594
liver - metabolism (1568) 1568
steatosis (1487) 1487
prevalence (1415) 1415
mice (1401) 1401
inflammation (1335) 1335
hepatic steatosis (1331) 1331
aged (1282) 1282
non-alcoholic fatty liver disease - pathology (1264) 1264
fatty liver-disease (1242) 1242
non-alcoholic fatty liver disease - metabolism (1227) 1227
nonalcoholic steatohepatitis (1200) 1200
non-alcoholic fatty liver disease - blood (1196) 1196
nafld (1130) 1130
body mass index (1084) 1084
metabolism (1012) 1012
analysis (1011) 1011
diabetes (986) 986
oxidative stress (976) 976
diet (926) 926
non-alcoholic fatty liver disease - complications (926) 926
biomarkers - blood (924) 924
nonalcoholic fatty liver disease (900) 900
biopsy (896) 896
endocrinology & metabolism (877) 877
rodents (830) 830
disease (825) 825
non-alcoholic steatohepatitis (806) 806
disease models, animal (793) 793
mice, inbred c57bl (784) 784
non-alcoholic fatty liver disease - epidemiology (772) 772
gastroenterology and hepatology (770) 770
insulin (765) 765
lipids (758) 758
risk (752) 752
cholesterol (748) 748
non-alcoholic fatty liver disease - etiology (733) 733
cross-sectional studies (727) 727
fatty liver - pathology (724) 724
nutrition & dietetics (722) 722
non-alcoholic fatty liver disease - diagnosis (718) 718
association (717) 717
alanine transaminase - blood (711) 711
diagnosis (708) 708
glucose (704) 704
non-alcoholic fatty liver disease - drug therapy (700) 700
liver - drug effects (672) 672
nutritional and metabolic diseases (667) 667
research (653) 653
rats (652) 652
fatty liver - metabolism (649) 649
fatty acids (637) 637
health aspects (627) 627
adolescent (624) 624
non-alcoholic fatty liver disease - genetics (621) 621
hepatology (612) 612
severity of illness index (612) 612
digestive system diseases (607) 607
fatty liver - blood (604) 604
care and treatment (581) 581
medicine (581) 581
obesity - complications (581) 581
type 2 diabetes (581) 581
liver cirrhosis (577) 577
expression (574) 574
pathogenesis (573) 573
physiological aspects (569) 569
cirrhosis (567) 567
gene expression (562) 562
triglycerides (559) 559
case-control studies (553) 553
risk-factors (548) 548
research article (540) 540
lipid metabolism (529) 529
young adult (526) 526
population (519) 519
disease progression (515) 515
biochemistry & molecular biology (514) 514
medical research (514) 514
medicine & public health (509) 509
hepatitis (505) 505
ultrasonography (505) 505
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8326) 8326
Chinese (150) 150
Russian (72) 72
Korean (65) 65
Portuguese (40) 40
Japanese (38) 38
Spanish (26) 26
German (16) 16
French (12) 12
Ukrainian (10) 10
Persian (8) 8
Norwegian (7) 7
Hungarian (5) 5
Italian (5) 5
Polish (4) 4
Turkish (3) 3
Icelandic (2) 2
Croatian (1) 1
Dutch (1) 1
Indonesian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Metabolism, clinical and experimental, ISSN 0026-0495, 2016, Volume 65, Issue 5, pp. 655 - 666
...), in which serum alanine aminotransferase (ALT) was used as a marker of liver disease. Results Obese individuals with NASH had higher activity of estimated... 
Endocrinology & Metabolism | Hepatic mRNA expression | Fatty acid desaturase | Non-alcoholic fatty liver disease | Serum fatty acid composition | Liver fatty acid composition | DIETARY-FAT | MESSENGER-RNA EXPRESSION | DE-NOVO LIPOGENESIS | LIVER FAT | ESTIMATED DESATURASE ACTIVITIES | SERUM-LIPIDS | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | TERM-FOLLOW-UP | GLUCOSE-TOLERANCE | Cholesterol Esters - metabolism | Non-alcoholic Fatty Liver Disease - pathology | Gastric Bypass | Liver - pathology | Liver - enzymology | Obesity, Morbid - surgery | Fatty Liver - pathology | Humans | Middle Aged | Fatty Liver - complications | Male | Metabolic Syndrome - metabolism | Risk | Cholesterol Esters - blood | Non-alcoholic Fatty Liver Disease - complications | Isoenzymes - metabolism | Adult | Female | Fatty Acids - blood | Fatty Acids - metabolism | Metabolic Syndrome - epidemiology | Body Mass Index | Fatty Acid Desaturases - genetics | Fatty Liver - metabolism | Cross-Sectional Studies | Isoenzymes - genetics | Fatty Acid Desaturases - metabolism | Liver - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Metabolic Syndrome - complications | Obesity, Morbid - complications | Triglycerides - metabolism | Gene Expression Regulation, Enzymologic | Triglycerides - blood | Metabolic Syndrome - pathology | Fatty Liver - epidemiology | Finland - epidemiology | Non-alcoholic Fatty Liver Disease - epidemiology | Cohort Studies | Physiological aspects | Obesity | RNA | Fatty acids | Medical research | Enzymes | Liver | Surgery | Alcoholics | Medicine, Experimental | Development and progression | Triglycerides
Journal Article
Journal Article
Journal Article
Diabetes care, ISSN 1935-5548, 2012, Volume 35, Issue 4, pp. 873 - 878
OBJECTIVE-Prediabetes and type 2 diabetes mellitus (T2DM) are believed to be common and associated with a worse metabolic profile in patients with nonalcoholic fatty liver disease (NAFLD... 
LIPOTOXICITY | PATHOGENESIS | OBESITY | ACIDS | INSULIN-RESISTANCE | GLUCOSE | ENDOCRINOLOGY & METABOLISM | STEATOHEPATITIS | SECRETION | MELLITUS | Diabetes Mellitus - blood | Prediabetic State - metabolism | Overweight - complications | Prevalence | Humans | Middle Aged | Fatty Liver - complications | Hyperglycemia - complications | Male | Obesity - blood | Case-Control Studies | Overweight - metabolism | Overweight - epidemiology | Non-alcoholic Fatty Liver Disease | Diabetes Complications - epidemiology | Adult | Female | Prediabetic State - epidemiology | Prediabetic State - blood | Fatty Liver - metabolism | Fatty Liver - blood | Obesity - complications | Diabetes Complications - metabolism | Metabolome - physiology | Diabetes Mellitus - metabolism | Prediabetic State - complications | Diabetes Complications - blood | Obesity - metabolism | Hyperglycemia - metabolism | Hyperglycemia - blood | Overweight - blood | Diabetes Mellitus - epidemiology | Obesity - epidemiology | Hyperglycemia - epidemiology | Fatty Liver - epidemiology | Type 2 diabetes | Medical research | Liver diseases | Development and progression | Research | Glucose | Insulin | Glucose tolerance tests | Fatty acids | Dextrose | Prevalence studies (Epidemiology) | Fatty liver | Medicine, Experimental | Prediabetic state | Hyperglycemia | Diabetes | Metabolism | Original Research
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 09/2017, Volume 23, Issue 36, pp. 6571 - 6592
In the last years new evidence has accumulated on nonalcoholic fatty liver disease (NAFLD... 
Type 2 diabetes | Screening | Clinical correlates | Pathogenesis | Biomarkers | Genetics | Liver histology | Nonalcoholic fatty liver disease | Diagnosis | Management | Metabolic syndrome | Epidemiology | LONG-TERM OUTCOMES | ATTENUATION PARAMETER CAP | SERUM URIC-ACID | FIBROSIS SCORING SYSTEMS | nonalcoholic fatty liver disease | HEPATOCELLULAR-CARCINOMA | Metabolic Syndrome | INSULIN-RESISTANCE | TOLL-LIKE RECEPTORS | CARDIOVASCULAR-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | TYPE-2 DIABETES-MELLITUS | MULTIPARAMETRIC MAGNETIC-RESONANCE | Metabolic Syndrome - etiology | Liver - pathology | Prevalence | Humans | Non-alcoholic Fatty Liver Disease - etiology | Mass Screening - methods | Diet, Reducing | Exercise Therapy | Diabetes Mellitus, Type 2 - epidemiology | Diagnostic Imaging - methods | Liver Neoplasms - etiology | Liver Neoplasms - epidemiology | Dyslipidemias - blood | Liver - diagnostic imaging | Chenodeoxycholic Acid - therapeutic use | Vitamin E - therapeutic use | Diabetes Mellitus, Type 2 - etiology | Dyslipidemias - etiology | Metabolic Syndrome - epidemiology | Hypoglycemic Agents - therapeutic use | Liver Function Tests | Risk Assessment | Risk Factors | Biomarkers - analysis | Non-alcoholic Fatty Liver Disease - therapy | Hyperuricemia - etiology | Chenodeoxycholic Acid - analogs & derivatives | Hyperuricemia - blood | Dyslipidemias - epidemiology | Non-alcoholic Fatty Liver Disease - diagnosis | Hyperuricemia - epidemiology | Non-alcoholic Fatty Liver Disease - epidemiology | Review
Journal Article